{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:12:10Z","timestamp":1778746330344,"version":"3.51.4"},"reference-count":197,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX20220273"],"award-info":[{"award-number":["BX20220273"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022\\u202FM712874"],"award-info":[{"award-number":["2022\\u202FM712874"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203343"],"award-info":[{"award-number":["82203343"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.bbcan.2025.189296","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T11:15:32Z","timestamp":1741346132000},"page":"189296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Role and mechanism of IL-33 in bacteria infection related gastric cancer continuum: From inflammation to tumor progression"],"prefix":"10.1016","volume":"1880","author":[{"given":"Yunxiao","family":"Ge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Janson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zigang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2025.189296_bb0005","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1053\/j.gastro.2023.12.022","article-title":"Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022","volume":"166","author":"Chen","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189296_bb0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41579-019-0303-5","article-title":"Bacterial survival: evolve and adapt or perish","volume":"18","author":"Chaguza","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/oxfordjournals.epirev.a018040","article-title":"Helicobacter pylori: epidemiology and routes of transmission","volume":"22","author":"Brown","year":"2000","journal-title":"Epidemiol. Rev."},{"key":"10.1016\/j.bbcan.2025.189296_bb0020","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41579-023-00959-2","article-title":"When Helicobacter pylori spells gastric cancer","volume":"21","author":"Taglialegna","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0025","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1136\/gutjnl-2017-315363","article-title":"Helicobacter pylori eradication treatment and the risk of gastric adenocarcinoma in a Western population","volume":"67","author":"Doorakkers","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189296_bb0030","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.cell.2024.01.004","article-title":"Streptococcus anginosus promotes gastric inflammation, atrophy, and tumorigenesis in mice","volume":"187","author":"Fu","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2025.189296_bb0035","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/SLA.0000000000005587","article-title":"A novel microbiome signature in gastric Cancer: a two independent cohort retrospective analysis","volume":"276","author":"Abate","year":"2022","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbcan.2025.189296_bb0040","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/apt.15675","article-title":"Gastric mucosal microbiota in a Mongolian population with gastric cancer and precursor conditions","volume":"51","author":"Gantuya","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bbcan.2025.189296_bb0045","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41586-022-05628-7","article-title":"Active eosinophils regulate host defence and immune responses in colitis","volume":"615","author":"Gurtner","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2025.189296_bb0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.immuni.2020.10.014","article-title":"Interleukin-33 promotes serotonin release from Enterochromaffin cells for intestinal homeostasis","volume":"54","author":"Chen","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2025.189296_bb0055","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1073\/pnas.1206587110","article-title":"IL-33 drives biphasic IL-13 production for noncanonical type 2 immunity against hookworms","volume":"110","author":"Hung","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2025.189296_bb0060","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s41423-023-01029-6","article-title":"Vitamin B6 regulates IL-33 homeostasis to alleviate type 2 inflammation","volume":"20","author":"Zhu","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0065","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1111\/all.15210","article-title":"Thrombin cleaves IL-33 and modulates IL-33-activated allergic lung inflammation","volume":"77","author":"Huang","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.bbcan.2025.189296_bb0070","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/all.15918","article-title":"Tezepelumab decreases airway epithelial IL-33 and T2-inflammation in response to viral stimulation in patients with asthma","volume":"79","author":"Sverrild","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.bbcan.2025.189296_bb0075","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1038\/s41590-023-01655-2","article-title":"Regulatory T cell-derived IL-1Ra suppresses the innate response to respiratory viral infection","volume":"24","author":"Griffith","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0080","doi-asserted-by":"crossref","first-page":"eaay1813","DOI":"10.1126\/science.aay1813","article-title":"Tumor-initiating cells establish an IL-33\u2013TGF-\u03b2 niche signaling loop to promote cancer progression","volume":"369","author":"Taniguchi","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2025.189296_bb0085","doi-asserted-by":"crossref","first-page":"14918","DOI":"10.1073\/pnas.1308651110","article-title":"Structural insights into the interaction of IL-33 with its receptors","volume":"110","author":"Liu","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2025.189296_bb0090","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature13577","article-title":"The alarmin IL-33 promotes regulatory T-cell function in the intestine","volume":"513","author":"Schiering","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2025.189296_bb0095","first-page":"517","article-title":"Th2 cell activation in chronic liver disease is driven by local IL33 and contributes to IL13-dependent Fibrogenesis, cellular and molecular","volume":"17","author":"Rei\u00dfing","year":"2024","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ccell.2022.01.003","article-title":"Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer","volume":"40","author":"Alam","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2025.189296_bb0105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-020-2015-4","article-title":"ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity","volume":"579","author":"Moral","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbcan.2025.189296_bb0110","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/s41423-024-01195-1","article-title":"Pogge von Strandmann, BAG6 restricts pancreatic cancer progression by suppressing the release of IL33-presenting extracellular vesicles and the activation of mast cells","volume":"21","author":"Alashkar Alhamwe","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0115","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1158\/0008-5472.CAN-20-2116","article-title":"Fibroblast-derived IL33 facilitates breast Cancer metastasis by modifying the immune microenvironment and driving type 2 immunity","volume":"80","author":"Shani","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189296_bb0120","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1158\/0008-5472.CAN-16-1602","article-title":"IL33 promotes Colon Cancer cell Stemness via JNK activation and macrophage recruitment","volume":"77","author":"Fang","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189296_bb0125","doi-asserted-by":"crossref","first-page":"897356","DOI":"10.3389\/fimmu.2022.897356","article-title":"The controversial role of IL-33 in lung Cancer","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0130","article-title":"Direct Targeting of CREB1 with Imperatorin Inhibits TGF\u03b22-ERK Signaling to Suppress Esophageal Cancer Metastasis","volume":"7","author":"Xu","year":"2020","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.bbcan.2025.189296_bb0135","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153242","article-title":"Targeting TNF-\u03b1\u2013producing macrophages activates antitumor immunity in pancreatic cancer via IL-33 signaling","volume":"7","author":"Dixit","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbcan.2025.189296_bb0140","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1016\/j.cell.2022.09.015","article-title":"A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors","volume":"185","author":"Dohlman","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2025.189296_bb0145","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1038\/s41388-020-1241-4","article-title":"Gastric cancer: genome damaged by bugs","volume":"39","author":"Zhao","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2025.189296_bb0150","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1073\/pnas.0506655103","article-title":"Molecular analysis of the bacterial microbiota in the human stomach","volume":"103","author":"Bik","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2025.189296_bb0155","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1053\/j.gastro.2019.10.019","article-title":"Risk factors and incidence of gastric Cancer after detection of Helicobacter pylori infection: a large cohort study","volume":"158","author":"Kumar","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189296_bb0160","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/gutjnl-2017-314281","article-title":"Mucosal microbiome dysbiosis in gastric carcinogenesis","volume":"67","author":"Coker","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189296_bb0165","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ebiom.2018.12.034","article-title":"Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer","volume":"40","author":"Liu","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbcan.2025.189296_bb0170","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1038\/s41591-024-03153-w","article-title":"Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial","volume":"30","author":"Pan","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbcan.2025.189296_bb0175","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1099\/jmm.0.007302-0","article-title":"Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls","volume":"58","author":"Dicksved","year":"2009","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0180","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/hel.12293","article-title":"Analysis of gastric microbiota by pyrosequencing: minor role of Bacteria other than Helicobacter pylori in the gastric carcinogenesis","volume":"21","author":"Jo","year":"2016","journal-title":"Helicobacter"},{"key":"10.1016\/j.bbcan.2025.189296_bb0185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semcancer.2022.05.001","article-title":"Microbiota and gastric cancer","volume":"86","author":"Bess\u00e8de","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0190","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/gutjnl-2017-314205","article-title":"Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota","volume":"67","author":"Ferreira","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189296_bb0195","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.3389\/fmicb.2017.02508","article-title":"The human gastric microbiome is predicated upon infection with Helicobacter pylori","volume":"8","author":"Klymiuk","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0200","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/INF.0000000000001383","article-title":"Characterization of the gastric microbiota in a pediatric population according to Helicobacter pylori status","volume":"36","author":"Llorca","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.bbcan.2025.189296_bb0205","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1136\/gutjnl-2024-332815","article-title":"Stomach microbiota in gastric cancer development and clinical implications","volume":"73","author":"Zeng","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189296_bb0210","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1136\/gutjnl-2019-319826","article-title":"Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication","volume":"69","author":"Sung","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189296_bb0215","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1128\/IAI.68.6.3657-3666.2000","article-title":"An OmpA-like protein from Acinetobacter spp. stimulates gastrin and interleukin-8 promoters","volume":"68","author":"Ofori-Darko","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.bbcan.2025.189296_bb0220","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3389\/fonc.2019.00608","article-title":"Detection of microbial 16S rRNA gene in the serum of patients with gastric Cancer","volume":"9","author":"Dong","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0225","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1093\/nar\/gkae188","article-title":"Molecular insights into the fine-tuning of pH-dependent ArsR-mediated regulation of the SabA adhesin in Helicobacter pylori","volume":"52","author":"\u00c5berg","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2025.189296_bb0230","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000190","article-title":"Increase in the lipopolysaccharide activity and accumulation of gram-negative Bacteria in the stomach with low acidity","volume":"11","author":"Sano","year":"2020","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0235","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/ismej.2013.33","article-title":"Immune status, antibiotic medication and pH are associated with changes in the stomach fluid microbiota","volume":"7","author":"von Rosenvinge","year":"2013","journal-title":"ISME J."},{"key":"10.1016\/j.bbcan.2025.189296_bb0240","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2015.20","article-title":"Influence of proton-pump inhibitors on the luminal microbiota in the gastrointestinal tract","volume":"6","author":"Tsuda","year":"2015","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118296","article-title":"Obligate and facultative anaerobic bacteria in targeted cancer therapy: current strategies and clinical applications","volume":"261","author":"Dr\u00f3\u017cd\u017c","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.bbcan.2025.189296_bb0250","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1158\/2159-8290.CD-24-0835","article-title":"Redefining the gastric microbes in promoting gastric tumorigenesis: the rise of the non-H. pylori","volume":"14","author":"Wong","year":"2024","journal-title":"Microbiome, Cancer Discov."},{"key":"10.1016\/j.bbcan.2025.189296_bb0255","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1128\/JCM.06262-11","article-title":"Probiotic mechanism of Lactobacillus gasseri OLL2716 strain against Helicobacter pylori","volume":"50","author":"Fujimura","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0260","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1440-1746.2006.04318.x","article-title":"Suppression of Helicobacter pylori-induced interleukin-8 production in vitro and within the gastric mucosa by a live Lactobacillus strain","volume":"21","author":"Tamura","year":"2006","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0265","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.3748\/wjg.v28.i47.6702","article-title":"Microbiota in the stomach and application of probiotics to gastroduodenal diseases","volume":"28","author":"Koga","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0270","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1574-695X.2002.tb00541.x","article-title":"Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri","volume":"32","author":"Mukai","year":"2002","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0275","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/s10120-021-01202-8","article-title":"Propionibacterium acnes overabundance in gastric cancer promote M2 polarization of macrophages via a TLR4\/PI3K\/Akt signaling","volume":"24","author":"Li","year":"2021","journal-title":"Gastr.Cancer : Off. J. Int. Gastri. Cancer Assoc. Japanese Gastric Cancer Association"},{"key":"10.1016\/j.bbcan.2025.189296_bb0280","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13045-024-01654-2","article-title":"Helicobacter pylori and gastric cancer: mechanisms and new perspectives","volume":"18","author":"Duan","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0285","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41420-022-01026-0","article-title":"Helicobacter pylori infection activates Wnt\/\u03b2-catenin pathway to promote the occurrence of gastritis by upregulating ASCL1 and AQP5","volume":"8","author":"Zuo","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189296_bb0290","doi-asserted-by":"crossref","first-page":"898240","DOI":"10.3389\/fbioe.2022.898240","article-title":"Anti-gastric Cancer activity of the cell-free culture supernatant of Serofluid dish and Lactiplantibacillus plantarum YT013","volume":"10","author":"Zhang","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0295","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1476-4598-13-40","article-title":"NF-kappaB-dependent MicroRNA-425 upregulation promotes gastric cancer cell growth by targeting PTEN upon IL-1\u03b2 induction","volume":"13","author":"Ma","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2025.189296_bb0300","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1053\/j.gastro.2008.12.003","article-title":"The Interleukin-6 family cytokine Interleukin-11 regulates homeostatic epithelial cell turnover and promotes gastric tumor development","volume":"136","author":"Howlett","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189296_bb0305","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1136\/gutjnl-2011-300539","article-title":"IL-11 is a parietal cell cytokine that induces atrophic gastritis","volume":"61","author":"Howlett","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189296_bb0310","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13046-015-0172-3","article-title":"Gastric cancer-derived mesenchymal stem cells prompt gastric cancer progression through secretion of interleukin-8","volume":"34","author":"Li","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189296_bb0315","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1158\/1078-0432.CCR-13-1221","article-title":"Interleukin-32 increases human gastric Cancer cell invasion associated with tumor progression and metastasis","volume":"20","author":"Tsai","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189296_bb0320","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1038\/s41467-019-10676-1","article-title":"IL-33-mediated mast cell activation promotes gastric cancer through macrophage mobilization","volume":"10","author":"Eissmann","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2025.189296_bb0325","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40425-019-0530-3","article-title":"Increased intratumoral mast cells foster immune suppression and gastric cancer progression through TNF-\u03b1-PD-L1 pathway","volume":"7","author":"Lv","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2025.189296_bb0330","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.4049\/jimmunol.176.11.6794","article-title":"Helicobacter pylori CagA-dependent macrophage migration inhibitory factor produced by gastric epithelial cells binds to CD74 and stimulates Procarcinogenic Events1","volume":"176","author":"Beswick","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0335","doi-asserted-by":"crossref","first-page":"692832","DOI":"10.3389\/fmicb.2021.692832","article-title":"Notch signaling ligand Jagged1 enhances macrophage-mediated response to Helicobacter pylori","volume":"12","author":"Wen","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0340","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13027-019-0221-1","article-title":"Association of host immunity with Helicobacter pylori infection in recurrent gastric cancer","volume":"14","author":"Sato","year":"2019","journal-title":"Infect. Agents Cancer"},{"key":"10.1016\/j.bbcan.2025.189296_bb0345","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1053\/j.gastro.2022.01.011","article-title":"Toll-like receptor 1 locus re-examined in a genome-wide association study update on anti-Helicobacter pylori IgG titers","volume":"162","author":"Lam","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189296_bb0350","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13568-022-01456-0","article-title":"Relationship between mucosal TNF-\u03b1 expression and Th1, Th17, Th22 and Treg responses in Helicobacter pylori infection","volume":"12","author":"Rahimian","year":"2022","journal-title":"AMB Express"},{"key":"10.1016\/j.bbcan.2025.189296_bb0355","article-title":"Gastric coinfection with thiopeptide-positive Cutibacterium acnes decreases FOXM1 and pro-inflammatory biomarker expression in a murine model of Helicobacter pylori-induced gastric cancer","volume":"12","author":"Lunger","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.bbcan.2025.189296_bb0360","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00772-21","article-title":"Gastric Non-Helicobacter pylori Urease-Positive Staphylococcus epidermidis and Streptococcus salivarius Isolated from Humans Have Contrasting Effects on H. pylori-Associated Gastric Pathology and Host Immune Responses in a Murine Model of Gastric Cancer","volume":"7","author":"Shen","year":"2022","journal-title":"mSphere"},{"key":"10.1016\/j.bbcan.2025.189296_bb0365","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112214","article-title":"Streptococcus mitis induces conversion of Helicobacter pylori to coccoid cells during co-culture in vitro","volume":"9","author":"Khosravi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2025.189296_bb0370","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.3390\/microorganisms10122495","article-title":"Effects of Helicobacter pylori and nitrate-reducing Bacteria Coculture on cells","volume":"10","author":"Ojima","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.bbcan.2025.189296_bb0375","doi-asserted-by":"crossref","first-page":"2347025","DOI":"10.1080\/19490976.2024.2347025","article-title":"M2 macrophages participate in ILC2 activation induced by Helicobacter pylori infection","volume":"16","author":"Peng","year":"2024","journal-title":"Gut microbes"},{"key":"10.1016\/j.bbcan.2025.189296_bb0380","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.immuni.2020.03.002","article-title":"Bacteria-induced group 2 innate lymphoid cells in the stomach provide immune protection through induction of IgA","volume":"52","author":"Satoh-Takayama","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2025.189296_bb0385","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.3389\/fimmu.2019.02326","article-title":"Lactobacillus gasseri suppresses the production of Proinflammatory cytokines in Helicobacter pylori-infected macrophages by inhibiting the expression of ADAM17","volume":"10","author":"Gebremariam","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0390","doi-asserted-by":"crossref","first-page":"1196084","DOI":"10.3389\/fcimb.2023.1196084","article-title":"Lactobacillus acidophilus NCFM and Lactiplantibacillus plantarum Lp-115 inhibit Helicobacter pylori colonization and gastric inflammation in a murine model","volume":"13","author":"Shen","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0395","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.12826","article-title":"NOD1 is required for Helicobacter pylori induction of IL-33 responses in gastric epithelial cells","volume":"20","author":"Tran","year":"2018","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051801","article-title":"Proregenerative activity of IL-33 in gastric tissue cells undergoing Helicobacter pylori-induced apoptosis","volume":"21","author":"Gonciarz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189296_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061385","article-title":"Interference of LPS H. pylori with IL-33-Driven Regeneration of Caviae porcellus Primary Gastric Epithelial Cells and Fibroblasts","volume":"10","author":"Gonciarz","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2025.189296_bb0410","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/imr.12619","article-title":"Interleukin-33 (IL-33): a nuclear cytokine from the IL-1 family","volume":"281","author":"Cayrol","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbcan.2025.189296_bb0415","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.it.2009.03.003","article-title":"Interleukin-33 - cytokine of dual function or novel alarmin?","volume":"30","author":"Haraldsen","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0420","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.4049\/jimmunol.0903818","article-title":"IL-33 mediates inflammatory responses in human lung tissue cells","volume":"185","author":"Yagami","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0425","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1182\/blood-2008-05-157818","article-title":"Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33","volume":"113","author":"Pecaric-Petkovic","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbcan.2025.189296_bb0430","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2025.189296_bb0435","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1189\/jlb.0407200","article-title":"IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals","volume":"82","author":"Ho","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002365","article-title":"IL33-mediated ILC2 activation and neutrophil IL5 production in the lung response after severe trauma: a reverse translation study from a human cohort to a mouse trauma model","volume":"14","author":"Xu","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.bbcan.2025.189296_bb0445","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nri2692","article-title":"Disease-associated functions of IL-33: the new kid in the IL-1 family","volume":"10","author":"Liew","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0450","first-page":"321","article-title":"Interleukin-33 biology with potential insights into human diseases, nature reviews","volume":"7","author":"Palmer","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.bbcan.2025.189296_bb0455","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease","volume":"16","author":"Liew","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0460","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2025.189296_bb0465","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and Cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2025.189296_bb0470","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1073\/pnas.1815016116","article-title":"IL-33\/regulatory T cell axis triggers the development of a tumor-promoting immune environment in chronic inflammation","volume":"116","author":"Ameri","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbcan.2025.189296_bb0475","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1038\/s41467-024-48441-8","article-title":"S. Demehri, Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression","volume":"15","author":"Park","year":"2023","journal-title":"Nat.Commun."},{"key":"10.1016\/j.bbcan.2025.189296_bb0480","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1158\/2159-8290.CD-24-0100","article-title":"Oncogenic KRAS-dependent stromal interleukin-33 directs the pancreatic microenvironment to promote tumor growth","volume":"14","author":"Donahue","year":"2024","journal-title":"Cancer Discov"},{"key":"10.1016\/j.bbcan.2025.189296_bb0485","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ccell.2022.01.003","article-title":"Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer","volume":"40","author":"Alam","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2025.189296_bb0490","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1158\/0008-5472.CAN-20-2116","article-title":"Fibroblast-derived IL33 facilitates breast Cancer metastasis by modifying the immune microenvironment and driving type 2 immunity","volume":"80","author":"Shani","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189296_bb0495","doi-asserted-by":"crossref","DOI":"10.1126\/science.aay1813","article-title":"Tumor-initiating cells establish an IL-33\u2013TGF-\u03b2 niche signaling loop to promote cancer progression","volume":"369","author":"Taniguchi","year":"2020","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.bbcan.2025.189296_bb0500","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1158\/0008-5472.CAN-16-1602","article-title":"IL33 promotes Colon Cancer cell Stemness via JNK activation and macrophage recruitment","volume":"77","author":"Fang","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189296_bb0505","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41423-020-0501-0","article-title":"The soluble glycoprotein NMB (GPNMB) produced by macrophages induces cancer stemness and metastasis via CD44 and IL-33","volume":"18","author":"Liguori","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0510","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13046-019-1052-z","article-title":"Tobacco smoke induced hepatic cancer stem cell-like properties through IL-33\/p38 pathway","volume":"38","author":"Xie","year":"2019","journal-title":"J. Experiment. & Clin. Cancer Res.: CR"},{"key":"10.1016\/j.bbcan.2025.189296_bb0515","doi-asserted-by":"crossref","first-page":"11385","DOI":"10.1038\/ncomms11385","article-title":"The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophages","volume":"7","author":"Yang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2025.189296_bb0520","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41590-019-0555-2","article-title":"An intrinsic role of IL-33 in Treg cell\u2013mediated tumor immunoevasion","volume":"21","author":"Hatzioannou","year":"2020","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0525","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1038\/ncomms13589","article-title":"Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment","volume":"7","author":"Akimoto","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2025.189296_bb0530","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ccell.2022.11.014","article-title":"IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer","volume":"41","author":"Blomberg","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2025.189296_bb0535","doi-asserted-by":"crossref","DOI":"10.1126\/science.abl7207","article-title":"Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion","volume":"378","author":"Zeng","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.bbcan.2025.189296_bb0540","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.7150\/thno.80483","article-title":"Alarmin IL-33 orchestrates antitumoral T cell responses to enhance sensitivity to 5-fluorouracil in colorectal cancer","volume":"13","author":"Song","year":"2023","journal-title":"Theranostics"},{"issue":"12","key":"10.1016\/j.bbcan.2025.189296_bb0545","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1172\/JCI88625","article-title":"IL-33 regulates the IgA-microbiota axis to restrain IL-1\u03b1-dependent colitis and tumorigenesis","volume":"126","author":"Malik","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbcan.2025.189296_bb0550","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41423-018-0166-0","article-title":"IL-33 drives the antitumor effects of dendritic cells via the induction of Tc9 cells","volume":"16","author":"Liu","year":"2018","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.bbcan.2025.189296_bb0555","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1158\/0008-5472.CAN-13-2729","article-title":"Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity","volume":"74","author":"Villarreal","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2025.189296_bb0560","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.562","article-title":"Interleukin-33 increases the sensitivity of multiple myeloma cells to the proteasome inhibitor bortezomib through reactive oxygen species-mediated inhibition of nuclear factor kappa-B signal and stemness properties","volume":"5","author":"Shao","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.bbcan.2025.189296_bb0565","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41419-018-0493-1","article-title":"Helicobacter pylori-induced IL-33 modulates mast cell responses, benefits bacterial growth, and contributes to gastritis","volume":"9","author":"Lv","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2025.189296_bb0570","doi-asserted-by":"crossref","first-page":"2536781","DOI":"10.1155\/2019\/2536781","article-title":"Arginase-1 and Treg Profile Appear to Modulate Inflammatory Process in Patients with Chronic Gastritis: IL-33 May Be the Alarm Cytokine in H. pylori-Positive Patients","volume":"2019","author":"da Silva","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bbcan.2025.189296_bb0575","doi-asserted-by":"crossref","first-page":"785","DOI":"10.18632\/oncotarget.28238","article-title":"IL-33 promotes gastric tumour growth in concert with activation and recruitment of inflammatory myeloid cells","volume":"13","author":"Tran","year":"2022","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbcan.2025.189296_bb0580","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41419-018-0493-1","article-title":"Helicobacter pylori-induced IL-33 modulates mast cell responses, benefits bacterial growth, and contributes to gastritis","volume":"9","author":"Lv","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bbcan.2025.189296_bb0585","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.7150\/ijbs.93573","article-title":"IL-33 accelerates chronic atrophic gastritis through AMPK-ULK1 Axis mediated autolysosomal degradation of GKN1","volume":"20","author":"Liu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbcan.2025.189296_bb0590","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3390\/cells8101290","article-title":"Helicobacter pylori induces IL-33 production and recruits ST-2 to lipid rafts to exacerbate inflammation","volume":"8","author":"Kuo","year":"2019","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.bbcan.2025.189296_bb0595","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jaci.2014.07.026","article-title":"Histologic eosinophilic gastritis is a systemic disorder associated with blood and extragastric eosinophilia, TH2 immunity, and a unique gastric transcriptome","volume":"134","author":"Caldwell","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110486","article-title":"Ligustilide, a novel SIRT1 agonist, alleviates lipopolysaccharide-induced acute lung injury through deacetylation of NICD","volume":"121","author":"Li","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0605","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/gutjnl-2016-312779","article-title":"A signalling cascade of IL-33 to IL-13 regulates metaplasia in the mouse stomach","volume":"67","author":"Petersen","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189296_bb0610","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16030522","article-title":"The importance of Th2 immune responses in mediating the progression of gastritis-associated metaplasia to gastric Cancer","volume":"16","author":"Privitera","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189296_bb0615","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/j.gastro.2020.09.040","article-title":"Interleukin 33 Triggers Early Eosinophil-Dependent Events Leading to Metaplasia in a Chronic Model of Gastritis-Prone Mice","volume":"160","author":"Salvo","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189296_bb0620","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1053\/j.gastro.2021.05.058","article-title":"WFDC2 promotes spasmolytic polypeptide-expressing metaplasia through the upregulation of IL33 in response to injury","volume":"161","author":"Jeong","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189296_bb0625","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.freeradbiomed.2023.03.024","article-title":"Mitochondrial GRIM-19 loss in parietal cells promotes spasmolytic polypeptide-expressing metaplasia through NLR family pyrin domain-containing 3 (NLRP3)-mediated IL-33 activation via a reactive oxygen species (ROS) -NRF2- Heme oxygenase-1(HO-1)\u2013NF\u2013\u043aB axis","volume":"202","author":"Zeng","year":"2023","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbcan.2025.189296_bb0630","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1007\/s10620-011-1760-5","article-title":"Serum Interleukin-33 levels in patients with gastric Cancer","volume":"56","author":"Sun","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbcan.2025.189296_bb0635","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2021.12000","article-title":"IL-33\/ST2 promotes the malignant progression of gastric cancer via the MAPK pathway","volume":"23","author":"Huang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbcan.2025.189296_bb0640","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s10620-014-3463-1","article-title":"IL-33 Promotes Gastric Cancer Cell Invasion and Migration Via ST2-ERK1\/2 Pathway","volume":"60","author":"HuXian","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bbcan.2025.189296_bb0645","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41388-022-02575-5","article-title":"A synergistic partnership between IL-33\/ST2 and Wnt pathway through Bcl-xL drives gastric cancer stemness and metastasis","volume":"42","author":"Kwon","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2025.189296_bb0650","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s44321-023-00012-y","article-title":"Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer","volume":"16","author":"Che","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbcan.2025.189296_bb0655","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22115792","article-title":"Proinflammatory Interleukin-33 induces Dichotomic effects on cell proliferation in Normal gastric epithelium and gastric Cancer","volume":"22","author":"Pisani","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189296_bb0660","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jare.2023.04.013","article-title":"Tumor-infiltrating mast cells stimulate ICOS+ regulatory T cells through an IL-33 and IL-2 axis to promote gastric cancer progression","volume":"57","author":"Lv","year":"2023","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bbcan.2025.189296_bb0665","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/s41388-019-1078-x","article-title":"The reciprocal interaction between tumor cells and activated fibroblasts mediated by TNF-\u03b1\/IL-33\/ST2L signaling promotes gastric cancer metastasis","volume":"39","author":"Zhou","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.bbcan.2025.189296_bb0670","doi-asserted-by":"crossref","first-page":"11738","DOI":"10.1080\/21655979.2021.2009412","article-title":"The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development","volume":"12","author":"Huang","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.bbcan.2025.189296_bb0675","doi-asserted-by":"crossref","first-page":"35116","DOI":"10.18632\/oncotarget.16627","article-title":"Serum IL-33 level is a predictor of progression-free survival after chemotherapy","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.bbcan.2025.189296_bb0680","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.3892\/or.2015.3898","article-title":"IL-33-induced JNK pathway activation confers gastric cancer chemotherapy resistance","volume":"33","author":"Ye","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2025.189296_bb0685","doi-asserted-by":"crossref","first-page":"26369","DOI":"10.1074\/jbc.M704916200","article-title":"Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation","volume":"282","author":"Hayakawa","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2025.189296_bb0690","doi-asserted-by":"crossref","first-page":"18660","DOI":"10.1073\/pnas.0705939104","article-title":"IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells","volume":"104","author":"Ali","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbcan.2025.189296_bb0695","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cyto.2008.03.008","article-title":"The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33","volume":"42","author":"Palmer","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.bbcan.2025.189296_bb0700","doi-asserted-by":"crossref","first-page":"eaax2945","DOI":"10.1126\/scitranslmed.aax2945","article-title":"Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis","volume":"11","author":"Chen","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbcan.2025.189296_bb0705","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/ACI.0000000000000981","article-title":"New biologics for food allergy","volume":"24","author":"Schuetz","year":"2024","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0710","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/cts.13157","article-title":"Pharmacokinetics and pharmacodynamics of itepekimab in healthy adults and patients with asthma: phase I first-in-human and first-in-patient trials","volume":"15","author":"Kosloski","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.bbcan.2025.189296_bb0715","doi-asserted-by":"crossref","first-page":"9825","DOI":"10.1038\/s41598-023-36642-y","article-title":"Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE\/EGFR to reduce inflammation and epithelial dysfunction","volume":"13","author":"England","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2025.189296_bb0720","first-page":"1288","article-title":"Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial, the lancet","volume":"9","author":"Rabe","year":"2021","journal-title":"Respir. Med."},{"issue":"18","key":"10.1016\/j.bbcan.2025.189296_bb0725","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa2024257","article-title":"efficacy and safety of Itepekimab in patients with moderate-to-severe asthma","volume":"385","author":"Wechsler","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2025.189296_bb0730","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/cpt.3147","article-title":"A randomized phase I study of the anti-Interleukin-33 antibody Tozorakimab in healthy adults and patients with chronic obstructive pulmonary disease","volume":"115","author":"Reid","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bbcan.2025.189296_bb0735","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/cpdd.1391","article-title":"A phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety, and Tolerability After Subcutaneous Administration of Tozorakimab in Healthy Chinese Participants","volume":"13","author":"Li","year":"2024","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.bbcan.2025.189296_bb0740","doi-asserted-by":"crossref","first-page":"E791","DOI":"10.1152\/ajpendo.00026.2024","article-title":"Advancements in diabetic kidney disease management: integrating innovative therapies and targeted drug development","volume":"326","author":"Ghose","year":"2024","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bbcan.2025.189296_bb0745","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.2147\/JIR.S320287","article-title":"Generation and characterization of Torudokimab (LY3375880): a monoclonal antibody that neutralizes Interleukin-33","volume":"14","author":"Okragly","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.bbcan.2025.189296_bb0750","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1111\/bcp.14361","article-title":"The first-in-human study of CNTO 7160, an anti-interleukin-33 receptor monoclonal antibody, in healthy subjects and patients with asthma or atopic dermatitis","volume":"86","author":"Nnane","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0755","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1054","article-title":"Safety, tolerability, and pharmacokinetics of a single ascending subcutaneous dose of GSK3772847 in healthy participants","volume":"11","author":"Pefani","year":"2023","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.bbcan.2025.189296_bb0760","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jacig.2022.07.002","article-title":"IL-33 receptor inhibition in subjects with uncontrolled asthma: a randomized, placebo-controlled trial","volume":"1","author":"Crim","year":"2022","journal-title":"J. Allerg. Clin. Immunol. Glob."},{"key":"10.1016\/j.bbcan.2025.189296_bb0765","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281205","article-title":"Efficacy and safety of GSK3772847 in participants with moderate-to-severe asthma with allergic fungal airway disease: a phase IIa randomized, multicenter, double-blind, sponsor-open, comparative trial","volume":"18","author":"Akinseye","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2025.189296_bb0770","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1054","article-title":"Safety, tolerability, and pharmacokinetics of a single ascending subcutaneous dose of GSK3772847 in healthy participants","volume":"11","author":"Pefani","year":"2023","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.bbcan.2025.189296_bb0775","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaci.2021.03.044","article-title":"Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: a randomized clinical trial","volume":"148","author":"Kelsen","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0780","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/CCM.0000000000005716","article-title":"Astegolimab or Efmarodocokin alfa in patients with severe COVID-19 pneumonia: a randomized, phase 2 trial","volume":"51","author":"Waters","year":"2023","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.bbcan.2025.189296_bb0785","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4155\/bio-2023-0115","article-title":"Factors contributing to the nonlinear pharmacokinetics of astegolimab: a close examination of potential causes","volume":"15","author":"Sperinde","year":"2023","journal-title":"Bioanalysis"},{"key":"10.1016\/j.bbcan.2025.189296_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122701","article-title":"Mechanistic role of RND3-regulated IL33\/ST2 signaling on cardiomyocyte senescence","volume":"348","author":"Wu","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.bbcan.2025.189296_bb0795","first-page":"1831","article-title":"Tristetraprolin prevents gastric metaplasia in mice by suppressing pathogenic inflammation, cellular and molecular","volume":"12","author":"Busada","year":"2021","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0800","doi-asserted-by":"crossref","first-page":"24505","DOI":"10.1038\/srep24505","article-title":"Tristetraprolin inhibits gastric cancer progression through suppression of IL-33","volume":"6","author":"Deng","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2025.189296_bb0805","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.intimp.2015.01.012","article-title":"Anti-inflammatory activity of flavonoids in Nepalese propolis is attributed to inhibition of the IL-33 signaling pathway","volume":"25","author":"Funakoshi-Tago","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0810","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.3390\/antiox11112238","article-title":"Quercetin ameliorates renal injury and Pyroptosis in lupus nephritis through inhibiting IL-33\/ST2 pathway in vitro and in vivo","volume":"11","author":"Chen","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.bbcan.2025.189296_bb0815","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.biopha.2018.06.048","article-title":"Therapeutic efficacy of zingerone against vancomycin-induced oxidative stress, inflammation, apoptosis and aquaporin 1 permeability in rat kidney","volume":"105","author":"Kandemir","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2025.189296_bb0820","article-title":"Interleukin-33\/ suppression of Tumorigenicity 2 in renal fibrosis: emerging roles in prognosis and treatment","volume":"12","author":"Tan","year":"2021","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0825","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1021\/acs.jpcb.2c00341","article-title":"Computational Cosolvent mapping analysis leads to identify salicylic acid analogs as weak inhibitors of ST2 and IL33 binding","volume":"126","author":"Yuan","year":"2022","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bbcan.2025.189296_bb0830","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1021\/acsptsci.3c00122","article-title":"Prophylactic mitigation of acute graft versus host disease by novel 2-(Pyrrolidin-1-ylmethyl)pyrrole-based Stimulation-2 (ST2) inhibitors","volume":"6","author":"Yuan","year":"2023","journal-title":"ACS Pharmacol. & Translat. Sci."},{"key":"10.1016\/j.bbcan.2025.189296_bb0835","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116942","article-title":"Structure-activity relationship of 1-(furan-2ylmethyl)Pyrrolidine-based Stimulation-2 (ST2) inhibitors for treating graft versus host disease","volume":"71","author":"Yuan","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbcan.2025.189296_bb0840","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99208","article-title":"From proteomics to discovery of first-in-class ST2 inhibitors active in vivo","volume":"3","author":"Ramadan","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbcan.2025.189296_bb0845","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/bkcs.10637","article-title":"Discovery of an interleukin 33 inhibitor by molecular docking simulation and NMR analysis","volume":"37","author":"Kim","year":"2016","journal-title":"Bull. Korean Chem. Soc."},{"key":"10.1016\/j.bbcan.2025.189296_bb0850","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1002\/asia.202100896","article-title":"Rational design, synthesis and evaluation of Oxazolo[4,5-c]-quinolinone analogs as novel Interleukin-33 inhibitors","volume":"16","author":"Kim","year":"2021","journal-title":"Chemistry \u2013 An Asian J."},{"key":"10.1016\/j.bbcan.2025.189296_bb0855","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1007\/s11030-021-10359-4","article-title":"Discovery of small molecular inhibitors for interleukin-33\/ST2 protein\u2013protein interaction: a virtual screening, molecular dynamics simulations and binding free energy calculations","volume":"26","author":"Mai","year":"2022","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bbcan.2025.189296_bb0860","doi-asserted-by":"crossref","first-page":"8696","DOI":"10.1080\/07391102.2021.1915180","article-title":"Virtual discovery of a hetero-cyclic compound from the universal natural product database (UNPD36) as a potential inhibitor of interleukin-33: molecular docking and dynamic simulations","volume":"40","author":"Adamu","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbcan.2025.189296_bb0865","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1038\/s41467-024-48441-8","article-title":"Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression","volume":"15","author":"Park","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.bbcan.2025.189296_bb0870","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0016-5085(97)70155-0","article-title":"A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain","volume":"112","author":"Lee","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189296_bb0875","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.3390\/cells8101290","article-title":"Helicobacter pylori induces IL-33 production and recruits ST-2 to lipid rafts to exacerbate inflammation","volume":"8","author":"Kuo","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bbcan.2025.189296_bb0880","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3389\/fcimb.2017.00434","article-title":"Gastric TFF1 expression from acute to chronic Helicobacter infection","volume":"7","author":"Esposito","year":"2017","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"5","key":"10.1016\/j.bbcan.2025.189296_bb0885","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/mpat.2000.0391","article-title":"Fumarate reductase is essential for Helicobacter pylori colonization of the mouse stomach","volume":"29","author":"Ge","year":"2000","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.bbcan.2025.189296_bb0890","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1080\/19490976.2018.1547612","article-title":"A novel probiotic, Lactobacillus johnsonii 456, resists acid and can persist in the human gut beyond the initial ingestion period","volume":"10","author":"Davoren","year":"2019","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bbcan.2025.189296_bb0895","doi-asserted-by":"crossref","first-page":"2313770","DOI":"10.1080\/19490976.2024.2313770","article-title":"Weizmannia coagulans BCF-01: a novel gastrogenic probiotic for Helicobacter pylori infection control","volume":"16","author":"Chen","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.bbcan.2025.189296_bb0900","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13099-023-00540-5","article-title":"Gut microbiota and host cytochrome P450 characteristics in the pseudo germ-free model: co-contributors to a diverse metabolic landscape","volume":"15","author":"Wang","year":"2023","journal-title":"Gut Pathogens"},{"key":"10.1016\/j.bbcan.2025.189296_bb0905","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1053\/j.gastro.2013.07.011","article-title":"Dual oxidases control release of hydrogen peroxide by the gastric epithelium to prevent Helicobacter felis infection and inflammation in mice","volume":"145","author":"Grasberger","year":"2013","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bbcan.2025.189296_bb0910","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0016-5085(00)70412-4","article-title":"Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer","volume":"118","author":"Wang","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189296_bb0915","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1053\/j.gastro.2010.09.048","article-title":"Lack of commensal Flora in Helicobacter pylori\u2013infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia","volume":"140","author":"Lofgren","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189296_bb0920","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1136\/gutjnl-2021-324489","article-title":"Human gastric microbiota transplantation recapitulates premalignant lesions in germ-free mice","volume":"71","author":"Kwon","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189296_bb0925","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00772-21","article-title":"Gastric Non-Helicobacter pylori Urease-Positive Staphylococcus epidermidis and Streptococcus salivarius Isolated from Humans Have Contrasting Effects on H. pylori-Associated Gastric Pathology and Host Immune Responses in a Murine Model of Gastric Cancer","volume":"7","author":"Shen","year":"2022","journal-title":"mSphere"},{"key":"10.1016\/j.bbcan.2025.189296_bb0930","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/gutjnl-2013-305178","article-title":"Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis","volume":"63","author":"Lertpiriyapong","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.bbcan.2025.189296_bb0935","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/jsfa.13059","article-title":"Effect of white jade snail secretion on antioxidant capacity and intestinal microbial diversity in mouse model of acute gastric ulcer","volume":"104","author":"Cheng","year":"2024","journal-title":"J. Sci. Food Agric."},{"key":"10.1016\/j.bbcan.2025.189296_bb0940","doi-asserted-by":"crossref","first-page":"15486","DOI":"10.3390\/ijms242015486","article-title":"Flavonoid-Rich Sambucus nigra berry extract enhances Nrf2\/HO-1 signaling pathway activation and exerts Antiulcerative effects in vivo","volume":"24","author":"Cicek","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2025.189296_bb0945","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1053\/j.gastro.2020.08.051","article-title":"Group 2 innate lymphoid cells coordinate damage response in the stomach","volume":"159","author":"Meyer","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbcan.2025.189296_bb0950","first-page":"203","article-title":"IL33 is a stomach Alarmin that initiates a skewed Th2 response to injury and infection, cellular and molecular","volume":"1","author":"Buzzelli","year":"2015","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0955","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.bbrc.2016.09.081","article-title":"IL-33 signaling fuels outgrowth and metastasis of human lung cancer","volume":"479","author":"Wang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2025.189296_bb0960","article-title":"Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma","volume":"13","author":"Yang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.bbcan.2025.189296_bb0965","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.3390\/cancers13092174","article-title":"IL-33-induced transcriptional activation of LPIN1 accelerates breast tumorigenesis","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbcan.2025.189296_bb0970","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4049\/jimmunol.1401344","article-title":"Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells","volume":"194","author":"Gao","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbcan.2025.189296_bb0975","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and Cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bbcan.2025.189296_bb0980","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/bjc.2015.433","article-title":"An antitumorigenic role for the IL-33 receptor, ST2L, in colon cancer","volume":"114","author":"O\u2019Donnell","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2025.189296_bb0985","first-page":"203","article-title":"IL33 is a stomach Alarmin that initiates a skewed Th2 response to injury and infection, cell Mol","volume":"1","author":"Buzzelli","year":"2015","journal-title":"Gastroenterol. Hepatol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25000381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X25000381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:40:16Z","timestamp":1778744416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X25000381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":197,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0304419X25000381"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189296","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role and mechanism of IL-33 in bacteria infection related gastric cancer continuum: From inflammation to tumor progression","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2025.189296","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"189296"}}